HARBOR CAPITAL ADVISORS, INC. Iovance Biotherapeutics, Inc. Transaction History

HARBOR CAPITAL ADVISORS, INC. portfolio value:

$358,000
portfolio value

HARBOR CAPITAL ADVISORS, INC. quarter portfolio value change:

-13.22%
quarter

Iovance Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -5.16% -2.03K shares -77K $9.58 37.40K
Q2 2022 share Decrease -6.52% -2.74K shares -267K $11.04 39.43K
Q1 2022 share Decrease -18.15% -9.35K shares -282K $16.65 42.18K
Q4 2021 share Increase 0.00% 51.54K shares 984K $19.42 51.54K